Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?
Won Sik JangMyung Soo KimWon Sik JeongKi Don ChangKang Su ChoWon-Sik HamKoon Ho RhaSung Joon HongYoung Deuk ChoiPublished in: BJU international (2017)
We showed that RARP in the setting of oligometastatic PCa is a safe and feasible procedure which improves oncological outcomes in terms of PFS and CSS. In addition, our data suggest that RARP effectively prevents urinary tract complications from PCa. The study highlights results from expert surgeons and highly selected patients that cannot be extrapolated to all patients with oligometastatic PCa; to confirm our findings, large, prospective, multicentre studies are required.
Keyphrases
- radical prostatectomy
- prostate cancer
- robot assisted
- urinary tract
- minimally invasive
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical trial
- randomized controlled trial
- prognostic factors
- bone mineral density
- mouse model
- type diabetes
- patient reported outcomes
- study protocol
- big data
- metabolic syndrome
- cross sectional
- double blind
- bone loss
- postmenopausal women
- weight loss
- artificial intelligence
- glycemic control